Silvercrest Asset Management’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,193,709
Closed -$2.15M 826
2024
Q2
$2.15M Buy
1,193,709
+15,344
+1% +$44.3K 0.01% 514
2024
Q1
$5.61M Buy
1,178,365
+51,881
+5% +$182K 0.04% 375
2023
Q4
$3.27M Hold
1,126,484
0.02% 434
2023
Q3
$1.52M Sell
1,126,484
-2,946
-0.3% -$5.16K 0.01% 527
2023
Q2
$2.43M Buy
1,129,430
+159,439
+16% +$387K 0.02% 460
2023
Q1
$2.82M Buy
969,991
+180,578
+23% +$910K 0.02% 422
2022
Q4
$5.42M Sell
789,413
-6,955
-0.9% -$32.8K 0.04% 333
2022
Q3
$2.53M Sell
796,368
-21,672
-3% -$78.8K 0.02% 420
2022
Q2
$2.63M Sell
818,040
-36,409
-4% -$106K 0.02% 428
2022
Q1
$2.59M Buy
854,449
+7,875
+0.9% +$26.6K 0.02% 466
2021
Q4
$3.78M Buy
846,574
+300,651
+55% +$1.47M 0.02% 415
2021
Q3
$3.58M Sell
545,923
-12,484
-2% -$120K 0.02% 425
2021
Q2
$8.95M Buy
558,407
+93,213
+20% +$1.29M 0.06% 294
2021
Q1
$5.75M Buy
465,194
+227,914
+96% +$3.49M 0.04% 357
2020
Q4
$2.64M Buy
+237,280
New +$1.78M 0.02% 440
2020
Q1
Sell
-285,561
Closed -$1.28M 774
2019
Q4
$1.28M Sell
285,561
-48,826
-15% -$303K 0.01% 512
2019
Q3
$2.78M Buy
+334,387
New +$3.65M 0.02% 428

Other funds holding STIM

Silvercrest Asset Management's STIM Position: Q3 2024 in Review

Silvercrest Asset Management sold out of Neuronetics (STIM) in Q3 2024, closing a stake of 1,193,709 shares — an estimated $2.15M sold.

Silvercrest Asset Management first reported a position in STIM in Q3 2019 and held it in 17 quarters. The position peaked at $8.95M in Q2 2021. 48 funds tracked by Wall St. Rank hold STIM as of Q3 2024.

  • Silvercrest Asset Management reported no remaining Neuronetics position as of Q3 2024 after selling out during the quarter.
  • Silvercrest Asset Management sold 1,193,709 Neuronetics shares in Q3 2024, an estimated $2.15M.
  • Silvercrest Asset Management first reported a position in Neuronetics in Q3 2019 and held it in 17 quarters.
  • Silvercrest Asset Management's Neuronetics position peaked at $8.95M in Q2 2021.
  • 48 funds tracked by Wall St. Rank held Neuronetics as of Q3 2024.

Based on Silvercrest Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.